Skip to Main Content

Paper Details

Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma.
Oncotarget
3
2020
Cytoplasmic FANCD2, FANCD2, Fanconi Anemia, Fanconi Anemia complementation group D2 protein, OSE, OSEs, Ovarian cancer, Patients, amyloid, anti-FANCD2 antibody, cFANCD2, cytoplasmic FANCD2, estrogen, gynecological cancers, ovarian cancer, ovarian carcinoma, ovarian surface epithelial cells, patient, patients, primary OSE cells
Author NameAffiliation
Sonali JoshiOregon Health & Science University
Sonali JoshiOregon Health & Science University and Knight Cancer Institute
Shawn P CampbellOregon Health & Science University
Shawn P CampbellOregon Health & Science University and Knight Cancer Institute
Jeong Y LimKnight Cancer Institute Oregon Health & Science University
Shannon K McWeeneyKnight Cancer Institute
Adam J KriegOregon Health & Science University
Yukie BeanOregon Health & Science University
Yukie BeanOregon Health & Science University and Knight Cancer Institute
Nadja PejovicSaint Louis University
Paulette Mhawech-Fauceglia
Tanja PejovicOregon Health & Science University
Tanja PejovicOregon Health & Science University and Knight Cancer Institute
  • 1 - 13

Datasets

Release 1.2